These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 11700389)
1. Vascular endothelial growth factor signaling pathway as an emerging target in hematologic malignancies. List AF Oncologist; 2001; 6 Suppl 5():24-31. PubMed ID: 11700389 [TBL] [Abstract][Full Text] [Related]
2. The vascular endothelial growth factor (VEGF) signaling pathway: a therapeutic target in patients with hematologic malignancies. Giles FJ Oncologist; 2001; 6 Suppl 5():32-9. PubMed ID: 11700390 [TBL] [Abstract][Full Text] [Related]
3. Angiogenic and lymphangiogenic molecules in hematological malignancies. Orpana A; Salven P Leuk Lymphoma; 2002 Feb; 43(2):219-24. PubMed ID: 11999550 [TBL] [Abstract][Full Text] [Related]
4. The emerging role of angiogenesis inhibitors in hematologic malignancies. Giles FJ Oncology (Williston Park); 2002 May; 16(5 Suppl 4):23-9. PubMed ID: 12102577 [TBL] [Abstract][Full Text] [Related]
5. Angiogenesis and angiogenic mediators in haematological malignancies. Mangi MH; Newland AC Br J Haematol; 2000 Oct; 111(1):43-51. PubMed ID: 11091181 [No Abstract] [Full Text] [Related]
6. Functions of the VEGF/VEGF receptor system in the vascular system. Breier G Semin Thromb Hemost; 2000; 26(5):553-9. PubMed ID: 11129412 [TBL] [Abstract][Full Text] [Related]
7. New vessel formation and aberrant VEGF/VEGFR signaling in acute leukemia: does it matter? de Bont ES; Neefjes VM; Rosati S; Vellenga E; Kamps WA Leuk Lymphoma; 2002 Oct; 43(10):1901-9. PubMed ID: 12481883 [TBL] [Abstract][Full Text] [Related]
8. Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. Nagy JA; Vasile E; Feng D; Sundberg C; Brown LF; Detmar MJ; Lawitts JA; Benjamin L; Tan X; Manseau EJ; Dvorak AM; Dvorak HF J Exp Med; 2002 Dec; 196(11):1497-506. PubMed ID: 12461084 [TBL] [Abstract][Full Text] [Related]
9. The role of vascular endothelial growth factor in angiogenesis. Ferrara N; Gerber HP Acta Haematol; 2001; 106(4):148-56. PubMed ID: 11815711 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor and its receptors in multiple myeloma. Ria R; Roccaro AM; Merchionne F; Vacca A; Dammacco F; Ribatti D Leukemia; 2003 Oct; 17(10):1961-6. PubMed ID: 14513045 [TBL] [Abstract][Full Text] [Related]
11. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677 [TBL] [Abstract][Full Text] [Related]
12. VEGFs, receptors and angiogenesis. Veikkola T; Alitalo K Semin Cancer Biol; 1999 Jun; 9(3):211-20. PubMed ID: 10343072 [TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor as a target opportunity in hematological malignancies. Bellamy WT Curr Opin Oncol; 2002 Nov; 14(6):649-56. PubMed ID: 12409656 [TBL] [Abstract][Full Text] [Related]
14. A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma. Vacca A; Ria R; Ribatti D; Semeraro F; Djonov V; Di Raimondo F; Dammacco F Haematologica; 2003 Feb; 88(2):176-85. PubMed ID: 12604407 [TBL] [Abstract][Full Text] [Related]
15. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. Ferrara N Semin Oncol; 2002 Dec; 29(6 Suppl 16):10-4. PubMed ID: 12516033 [TBL] [Abstract][Full Text] [Related]
16. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Bellamy WT; Richter L; Frutiger Y; Grogan TM Cancer Res; 1999 Feb; 59(3):728-33. PubMed ID: 9973224 [TBL] [Abstract][Full Text] [Related]